Drug patch approved for treatment of depression

Published: 3-Mar-2006

Somerset Pharmaceuticals' Emsam (selegiline) has become the first skin (transdermal) patch to gain US Food and Drug Administration (FDA) approval for the treatment of major depression.


Somerset Pharmaceuticals' Emsam (selegiline) has become the first skin (transdermal) patch to gain US Food and Drug Administration (FDA) approval for the treatment of major depression.

You may also like